You are here: Industry Insights > immune response

News List

Moderna informs COVID-19 vaccine induced immune response in older adults in small study expresspharma
August 27, 2020
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in older adults.
Translate Bio, Sanofi Covid-19 vaccine elicits immune response in animals pharmaceutical-technology
August 26, 2020
Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies.
Intranasal vaccine made from peptide nanofibres shows efficacy in mice europeanpharmaceuticalreview
August 12, 2020
A new vaccine platform using self-assembling peptide nanofibres tagged with antigens has been tested successfully in mice, eliciting a strong immune response.
COVID-19 vaccine safely induces immune response in Chinese trial europeanpharmaceuticalreview
July 22, 2020
Investigators report CanSino Biologics’ Ad5-nCoV vaccine induced antibody production with mild to moderate side effects in patients.
Oxford University coronavirus vaccine induces immune response: Lancet expresspharma
July 21, 2020
The findings are seen as promising, but experts feel it is too soon to know if this is enough to offer protection as larger trials get underway.
Australian researchers map immune response to Covid-19 pharmaceutical-technology
March 18, 2020
Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have mapped Covid-19 immune response from an affected patient in the country.
Combining antibiotics with immune response to treat antibiotic resistant bacteria pharmaceutical-technology
July 12, 2018
Researchers from Lehigh University in the US have designed a new possible solution for antibiotic resistant bacteria by combining antibiotics with the exploitation of the body’s immune response.
Ebola vaccines in a trial elicit immune response for a year long europeanpharmaceuticalreview
October 16, 2017
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year…
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study cphi-online
May 31, 2017
Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.
Inovio’s NIH-backed HIV vaccine shows near 100% immune response rate in early test fiercepharma
May 27, 2017
Inovio is one step closer in the race to create an effective HIV vaccine. Data from an early-stage clinical study showed that its Pennvax-GP could elicit an immune response in nearly all participants.

Previous page 1 2 Next page